1. Home
  2. RDY vs GLP Comparison

RDY vs GLP Comparison

Compare RDY & GLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • GLP
  • Stock Information
  • Founded
  • RDY 1984
  • GLP 2005
  • Country
  • RDY India
  • GLP United States
  • Employees
  • RDY N/A
  • GLP N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • GLP Oil Refining/Marketing
  • Sector
  • RDY Health Care
  • GLP Energy
  • Exchange
  • RDY Nasdaq
  • GLP Nasdaq
  • Market Cap
  • RDY 2.1B
  • GLP 1.8B
  • IPO Year
  • RDY N/A
  • GLP 2005
  • Fundamental
  • Price
  • RDY $15.23
  • GLP $54.17
  • Analyst Decision
  • RDY Strong Buy
  • GLP Hold
  • Analyst Count
  • RDY 2
  • GLP 1
  • Target Price
  • RDY $16.95
  • GLP $56.00
  • AVG Volume (30 Days)
  • RDY 1.7M
  • GLP 54.7K
  • Earning Date
  • RDY 07-28-2025
  • GLP 08-06-2025
  • Dividend Yield
  • RDY 0.63%
  • GLP 5.32%
  • EPS Growth
  • RDY 1.47
  • GLP 16.18
  • EPS
  • RDY 0.79
  • GLP 3.13
  • Revenue
  • RDY $3,809,801,863.00
  • GLP $17,610,371,000.00
  • Revenue This Year
  • RDY $10.24
  • GLP $38.58
  • Revenue Next Year
  • RDY N/A
  • GLP $17.34
  • P/E Ratio
  • RDY $19.24
  • GLP $17.63
  • Revenue Growth
  • RDY 16.61
  • GLP 6.04
  • 52 Week Low
  • RDY $12.26
  • GLP $37.00
  • 52 Week High
  • RDY $16.89
  • GLP $60.00
  • Technical
  • Relative Strength Index (RSI)
  • RDY 55.04
  • GLP 55.42
  • Support Level
  • RDY $15.16
  • GLP $53.59
  • Resistance Level
  • RDY $16.17
  • GLP $56.51
  • Average True Range (ATR)
  • RDY 0.20
  • GLP 2.03
  • MACD
  • RDY -0.07
  • GLP 0.06
  • Stochastic Oscillator
  • RDY 39.74
  • GLP 48.12

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About GLP Global Partners LP Common Units representing Limited Partner Interests

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

Share on Social Networks: